Odevixibat therapy in progressive familial intrahepatic cholestasis with MYO5B variants: a retrospective case series

被引:0
|
作者
Bertrand Roquelaure [1 ]
Marco Sciveres [2 ]
Tassos Grammatikopoulos [3 ]
Eberhard Lurz [4 ]
Folke Freudenberg [5 ]
Dalila Habes [6 ]
Lionel Thevathasan [7 ]
Fatine Elaraki [8 ]
Emmanuel Gonzales [9 ]
机构
[1] APHM,Service de Pédiatrie Multidisciplinaire
[2] Hôpital de la Timone Enfants,Pediatric Hepatology and Pediatric Liver Transplantation
[3] ISMETT,Liver Unit and Liver Transplant Program
[4] University of Pittsburgh Medical Center Italy,Institute of Liver Studies
[5] Bambino Gesù Children Hospital,Paediatric Liver, GI and Nutrition Centre and Mowat Labs
[6] King’s College London,Division of Paediatric Gastroenterology and Hepatology, Dr. von Hauner Children’s Hospital
[7] King’s College Hospital NHS Trust,Hépatologie et Transplantation Hépatique Pédiatriques, Centre de Référence de l’Atrésie des Voies Biliaires et des Cholestases Génétiques, AP
[8] University Hospital Munich,HP
[9] LMU,undefined
[10] Klinikum Dritter Orden,undefined
[11] Division of Pediatric Gastroenterology and Hepatology,undefined
[12] FSMR FILFOIE,undefined
[13] ERN RARE LIVER,undefined
[14] Hôpital Bicêtre,undefined
[15] Université Paris-Saclay,undefined
[16] Inserm U 1193,undefined
[17] LT Associates Ltd,undefined
[18] Ipsen,undefined
关键词
Progressive Familial intrahepatic cholestasis; Myosin 5B; Pruritus; Bilirubin; Odevixibat; Serum bile acid; Ileal bile acid transporter inhibitor;
D O I
10.1186/s13023-025-03728-x
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 31 条
  • [1] Practical Considerations for Odevixibat Treatment in Patients with Progressive Familial Intrahepatic Cholestasis: A Single-Center Case Series
    Marx, Milena
    Hartleif, Steffen
    Hilberath, Johannes
    Berg, Christoph P.
    Tsiflikas, Ilias
    Singer, Stephan
    Sturm, Ekkehard
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [2] Odevixibat in progressive familial intrahepatic cholestasis: a profile of its use
    Heo, Young-A
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (07) : 301 - 307
  • [3] Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis
    Bedoyan, Sarah M.
    Lovell, Olya T.
    Horslen, Simon P.
    Squires, James E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (16) : 1771 - 1779
  • [4] A Novel Homozygous Mutation in the MYO5B Gene Associated With Normal-Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis
    Aksu, Nihal Uyar
    Gorukmez, Orhan
    Gorukmez, Ozlem
    Uncuoglu, Aysen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [5] Newer variants of progressive familial intrahepatic cholestasis
    Vinayagamoorthy, Vignesh
    Srivastava, Anshu
    Sen Sarma, Moinak
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (12) : 2024 - 2038
  • [6] Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis
    Di Giorgio, Angelo
    Sciveres, Marco
    Fuoti, Maurizio
    Calvo, Pierluigi
    Cananzi, Mara
    Lleo, Ana
    Gatti, Simona
    Indolfi, Giuseppe
    Madeo, Annalisa
    Mandato, Claudia
    Nuti, Federica
    Zanchi, Chiara
    Carioli, Greta
    Ghirardi, Arianna
    Nicastro, Emanuele
    D'Antiga, Lorenzo
    JHEP REPORTS, 2025, 7 (04)
  • [7] Odevixibat: A Novel Bile Salt Inhibitor Treatment for Pruritus in Progressive Familial Intrahepatic Cholestasis
    Flattmann, Farrah E.
    Mohiuddin, Farhan S.
    Singh, Anjuni
    Tandon, Anamika
    Lockett, Stewart J.
    Hirsch, Jon D.
    Mosieri, Chizoba N.
    Kaye, Adam M.
    Varrassi, Giustino
    Ahmadzadeh, Shahab
    Shekoohi, Sahar
    Kaye, Alan D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [8] Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis
    Slavetinsky, Christoph
    Sturm, Ekkehard
    BMJ CASE REPORTS, 2020, 13 (06)
  • [9] Progressive familial intrahepatic cholestasis type 4: a case report
    Abokandil, Mohamed Abdelmalak
    Waheeb, Saber
    Zaghloul, Wessam
    Abdelgawad, Manal
    Abdelhady, Mona
    Mansy, Mohamed
    Kotb, Mostafa
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [10] Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis
    Yi, Sojeong
    Kim, Insook
    Hager, Rebecca
    Strazzeri, Marian M.
    Garrard, Lili
    Matsubayashi, Toru
    Mehta, Ruby
    GASTRO HEP ADVANCES, 2025, 4 (04):